Meisner Lara's Form 4 filing
Viridian Therapeutics, Inc.DEVRDN · filed Jun 20, 2023
- Accession no.
- 0000899243-23-015998
- Filed
- Jun 20, 2023
- Trade date
- Jun 15-16, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $64.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meisner LaraCIK 0001883986 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | Common Stock | MOption exerciseAcquired | +2,269 | $23.03 | +$52,255.07 | 32,240 | Direct | |
| Jun 15, 2023 | Common Stock | SSaleDisposed | −2,269 | $28.02F1 | −$63,577.38 | 29,971 | Direct | |
| Jun 16, 2023 | Common Stock | MOption exerciseAcquired | +27 | $23.03 | +$621.81 | 29,998 | Direct | |
| Jun 16, 2023 | Common Stock | SSaleDisposed | −27 | $28.35 | −$765.45 | 29,971 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | Common Stock | MOption exerciseDisposed | −2,269 | $0.00 | $0 | 37,481 | Direct | |
| Jun 16, 2023 | Common Stock | MOption exerciseDisposed | −28 | $0.00 | $0 | 37,453 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 7, 2023 (the "Plan") in multiple trades at prices ranging from $28.00 to $28.09. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.